Skip to content

Author

Paul R. Walker

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Molecular Residual Disease in Non-Small Cell Lung Cancer: Technology or Patient Outcomes?

Molecular residual disease (MRD) testing approaches with plasma next-generation sequencing (NGS) testing to identify circulating tumor DNA (ctDNA) in resectable-stage non-small cell lung cancer (NSCLC) are evolving. The MRD concept is to better guide perioperative systemic treatment and identify recurrent NSCLC before...

Paul R. Walker · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.